US20200093600A1 - Medical System For Annuloplasty - Google Patents
Medical System For Annuloplasty Download PDFInfo
- Publication number
- US20200093600A1 US20200093600A1 US16/677,553 US201916677553A US2020093600A1 US 20200093600 A1 US20200093600 A1 US 20200093600A1 US 201916677553 A US201916677553 A US 201916677553A US 2020093600 A1 US2020093600 A1 US 2020093600A1
- Authority
- US
- United States
- Prior art keywords
- displacement unit
- annulus
- shape
- coronary sinus
- expandable portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2445—Annuloplasty rings in direct contact with the valve annulus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/064—Surgical staples, i.e. penetrating the tissue
- A61B17/0644—Surgical staples, i.e. penetrating the tissue penetrating the tissue, deformable to closed position
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
- A61B17/072—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/12036—Type of occlusion partial occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/1204—Type of occlusion temporary occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12136—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12163—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a string of elements connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2451—Inserts in the coronary sinus for correcting the valve shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2466—Delivery devices therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/02—Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors
- A61B17/0218—Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors for minimally invasive surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0091—Three-dimensional shapes helically-coiled or spirally-coiled, i.e. having a 2-D spiral cross-section
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0003—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having an inflatable pocket filled with fluid, e.g. liquid or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0059—Additional features; Implant or prostheses properties not otherwise provided for temporary
Definitions
- This invention pertains in general to the field of annuloplasty devices for treating a defective mitral valve. More particularly the invention relates to a medical system of devices for treating a defective mitral valve via coronary sinus and an annuloplasty implant for fixation of the annulus, and a method therefor.
- Mitral valve repair is frequently performed with aid of an annuloplasty ring, used to reduce the diameter of the annulus, or modify the geometry of the annulus in any other way, or aid as a generally supporting structure during the valve replacement or repair procedure.
- Implants have previously been introduced into the coronary sinus (CS) in order to affect the shape of the valve annulus and thereby the valve function.
- CS coronary sinus
- U.S. Pat. No. 6,210,432 and WO02/062270 discloses such implant that is aimed to replace annuloplasty rings.
- Permanent implant have several disadvantageous effects, for example since they are implanted into the CS which is a source for later complications.
- a problem with the prior art implants in the CS is that such implants may be less effective in retaining the desired geometry of the annulus. It may be necessary for the implants to be positioned in the CS for a lengthy time in order to sustain the correct function of the valve. This pose significant requirements on the long-term function of the implant, that may not implants as effective as annuloplasty rings to start with.
- a further problem with prior art is thus that complex and difficult-to-operate devices must be deployed in the CS, that may require frequent adjustment and repositioning to ensure the correct function over time.
- Another problem with prior art devices is the traumatic effects on the CS itself, due to fixation structures that must ensure the correct position of the device in the CS over time. Another problem is to ensure that a significant part of the annulus is reshaped while providing for atraumatic engagement with the anatomy.
- EP2072027 discloses a device for insertion into the CS. It is a segmented device that can change its radius. A balloon at the distal end for providing a temporary fixation point at the distal end is disclosed.
- US 2007/185572A1 discloses an implant for treating a mitral valve, comprising an elongate member having a spiral shape, the elongate member having a proximal end portion and a distal end portion, an expandable proximal anchor joined to the proximal end portion of the elongate body, and an expandable distal anchor joined to the distal end portion of the elongate body.
- the elongate member is configured to adjust from an elongated state to a shortened state after delivery into a coronary sinus for reshaping a mitral annulus.
- WO 2004/084746A2 discloses a device for treatment of insufficiency of a heart valve comprising a longitudinal body that can have at least two different forms, namely one easily introduced into the coronary sinus or the great cardiac vein and to the vessel adaptable form, and a second one the position of the heart valve affecting form.
- the second form when the longitudinal body has been placed into the said vein, presses the vessel and thereby the orifice of the heart valve in parallel towards a closed position.
- US 2008/103590A1 discloses a CS device having a coil, which is disposed between straight sections and a tether for adjusting the stiffness of a spring and the relative force applied by the device against the adjacent tissue and mitral valve annulus.
- the mitral valve annulus reshaping device includes a distal stent and a proximal stent that are also preferably formed of SMA. Distal stent is allowed to expand as it converts from UM toward its austenitic state once the constraint of the catheter is removed.
- US 2004/153147A1 discloses a method and device for reducing mitral regurgitation.
- An elongated body is positioned in a coronary sinus of a patient in a vicinity of a heart mitral valve posterior leaflet.
- the body is adapted to straighten a natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet to move a posterior annulus anteriorly, which in turn moves the posterior leaflet anteriorly, thereby to improve leaflet coaptation.
- an improved medical system for performing downsizing and reshaping of the valve annulus would be advantageous and in particular allowing for ensuring long-term functioning, less complex procedure, and less traumatic effects on the anatomy and increased patient safety.
- embodiments of the present invention preferably seeks to mitigate, alleviate or eliminate one or more deficiencies, disadvantages or issues in the art, such as the above-identified, singly or in any combination by providing a device according to the appended patent claims.
- a medical system for treating a defective mitral valve (MV) having an annulus (A) comprises in combination a removable and flexible elongate displacement unit for temporary insertion into a coronary sinus (CS) adjacent the valve, wherein the displacement unit has a delivery state for delivery into said CS, and an activated state to which the displacement unit is temporarily and reversibly transferable from the delivery state.
- CS coronary sinus
- the displacement unit comprises a proximal reversibly expandable portion, a distal anchoring portion being movable in relation to the proximal expandable portion in a longitudinal direction of the displacement unit to the activated state in which the shape of the annulus is modified to a modified shape (A′); and an annuloplasty device for permanent fixation at the mitral valve annulus by annuloplasty of the valve when the modified shape is obtained.
- the annuloplasty device comprises a fixation structure that is adapted to retain the modified shape.
- a method for treating a defective mitral valve having an annulus comprising; inserting a flexible and removable elongate displacement unit in a delivery state into a coronary sinus (CS) adjacent said valve, positioning a proximal expandable portion against a tissue wall at the entrance of said CS, positioning a distal anchoring portion inside said CS, activating said displacement unit in an activated state whereby said distal anchoring portion is moved in a longitudinal direction of said displacement unit to reduce the distance (L) between said distal anchoring portion and said proximal expandable portion, to a shorter or reduced distance (L′) such that the shape of the annulus is modified to a modified shape (A′), fixating an annuloplasty device at the mitral valve annulus when said modified shape is obtained, whereby said annuloplasty device comprises a fixation structure that is adapted to retain said modified shape, removing said elongate displacement unit after temporary activation in the activated state.
- CS coronary sinus
- a removable and flexible elongate displacement unit for temporary insertion into a coronary sinus (CS) adjacent a defective mitral valve (MV) having an annulus (A) is disclosed.
- the displacement unit has a delivery state for delivery into said CS, and an activated state to which the displacement unit is temporarily and reversibly transferable from said delivery state.
- the displacement unit comprises a proximal reversibly expandable portion, a distal anchoring portion being movable in relation to said proximal expandable portion in a longitudinal direction of said displacement unit to said activated state in which the shape of the annulus is modified to a modified shape (A′).
- a medical system for treating a defective mitral valve having an annulus comprising in combination; a removable elongate displacement unit for temporary insertion into a coronary sinus (CS) adjacent the mitral valve, wherein the displacement unit has a delivery state for delivery into the CS, and an activated state to which the displacement unit is temporarily and reversibly transferable from the delivery state, whereby at least a portion of the displacement unit is temporarily movable in a radial direction of the CS towards the valve in such a manner that the shape of the annulus is modified to a modified shape.
- the medical system further comprising an annuloplasty device for permanent fixation at the mitral valve annulus by annuloplasty of the valve when the modified shape is obtained, wherein the annuloplasty device comprises a fixation structure that is adapted to retain the modified shape.
- a method for treating a defective mitral valve having an annulus comprising; inserting a removable elongate displacement unit in a delivery state into a coronary sinus (CS) adjacent the mitral valve; activating the displacement unit in an activated state whereby at least a portion of the displacement unit is moved in a radial direction of the CS towards the valve in such a manner that the shape of the annulus is modified to a modified shape; fixating an annuloplasty device at the mitral valve annulus when then modified shape is obtained, whereby the annuloplasty device comprises a fixation structure that is adapted to retain the modified shape; and removing the elongate displacement unit after temporary activation in the activated state.
- CS coronary sinus
- Some embodiments of the invention provide for long-term functioning of the mitral valve.
- Some embodiments of the invention provide for less complex downsizing procedures of the mitral valve.
- Some embodiments of the invention provide for a reduced risk of damaging the anatomy such as the CS.
- Some embodiments of the invention provide for a secure downsizing while at the same time reducing the risk of damaging the anatomy such as the CS.
- Some embodiments of the invention provide for improved downsizing of the mitral valve annulus while ensuring an atraumatic procedure.
- Some embodiments of the invention also provide for reduced risk of long-term negative effects of CS implants.
- FIG. 1 is an illustration of the heart showing the coronary sinus in relation to the mitral valve in a side-view
- FIG. 2 a is an illustration of the heart showing the coronary sinus in relation to a diseased mitral valve in a top-down view;
- FIG. 2 b is an illustration of a part of a medical system according to embodiments of the invention in a first state
- FIG. 2 c is an illustration of a part of a medical system according to embodiments of the invention in a second state
- FIG. 2 d is an illustration of a medical system according to embodiments of the invention.
- FIG. 2 e is an illustration of a part of a medical system according to embodiments of the invention.
- FIG. 2 f is an illustration of a part of a medical system according to embodiments of the invention.
- FIG. 3 a is an illustration of a part of a medical system according to embodiments of the invention in a first state
- FIG. 3 b is an illustration of a medical system according to embodiments of the invention.
- FIG. 4 a is an illustration of a part of a medical system according to embodiments of the invention in a perspective view
- FIG. 4 b is an illustration of a medical system according to embodiments of the invention in a perspective view
- FIGS. 5 a - b are illustrations of a part of a medical system according to embodiments of the invention in a side views;
- FIG. 6 is an illustration of a part of a medical system according to an embodiment of the invention in a side view
- FIG. 7 is an illustration of a part of a medical system according to an embodiment of the invention in a side view
- FIGS. 8 a - b are illustrations of a part of a medical system according to embodiments of the invention in a side views;
- FIGS. 9 a - b are illustrations of a part of a medical system according to embodiments of the invention in a top-down view
- FIGS. 10 a - b are illustrations of a part of a medical system according to embodiments of the invention in a top-down view;
- FIGS. 11 a - c are illustrations of a part of a medical system according to embodiments of the invention in a top-down view;
- FIG. 12 is a flow chart illustrating a method of treating a defective mitral valve according to embodiments of the invention.
- FIGS. 13 a - c are illustrations of a displacement unit according to embodiments of the invention, also being part of a medical system according to embodiments of the invention;
- FIGS. 14 a - b are illustrations of a displacement unit according to embodiments of the invention, also being part of a medical system according to embodiments of the invention.
- FIG. 15 is an illustration of a displacement unit according to embodiments of the invention, also being part of a medical system according to embodiments of the invention.
- FIG. 16 is an illustration of a displacement unit according to embodiments of the invention, in use, also being part of a medical system according to embodiments of the invention;
- FIG. 17 a is an illustration of a displacement unit according to embodiments of the invention, also being part of a medical system according to embodiments of the invention.
- FIG. 17 b is an illustration of a medical system according to embodiments of the invention.
- FIGS. 18 a - b are illustrations of a displacement unit according to embodiments of the invention, also being part of a medical system according to embodiments of the invention.
- FIGS. 19 a - b are illustrations of a displacement unit according to embodiments of the invention, also being part of a medical system according to embodiments of the invention.
- FIG. 20 is a flow chart illustrating a method of treating a defective mitral valve according to embodiments of the invention.
- FIG. 1 is an illustration of the heart showing the coronary sinus (CS) in relation to the mitral valve (MV) in a side-view.
- the CS lies adjacent the MV and follows a curvature around the annulus (A) of the MV, which is further illustrated in the top-down view of FIG. 2 a.
- FIG. 2 d shows a medical system 100 for treating a defective mitral valve (MV) having an annulus (A) according to an embodiment of the invention.
- the system comprises in combination a removable elongate displacement unit 101 and a annuloplasty device 102 for permanent fixation at the mitral valve.
- the displacement unit 101 is adapted for temporary insertion into the CS adjacent the MV, and it has a delivery state for delivery into the CS. In the delivery state, the displacement unit 101 is bendable in an arch shape at a portion of the displacement unit 101 upon said delivery, i.e. as it is positioned in the CS, and can therefore adapt to the anatomy of the CS and conform to the curvature of the CS adjacent a dilated MV, which is illustrated in FIG. 2 b .
- the displacement unit 101 is removable and adapted for temporary insertion in the CS, it may be permanently attached to a delivery unit 111 , such as a delivery wire, guide wire or the like.
- the displacement unit 101 has further an activated state to which the displacement unit is temporarily and reversibly transferable from the delivery state.
- at least a portion of the displacement unit 101 is temporarily movable in a radial direction (r) of the CS towards the MV in such a manner that the shape of the annulus (A) is modified to a modified shape (A′), as the displacement unit 101 is transferred its activated state, which is illustrated in FIG. 2 c .
- efficient downsizing of the valve annulus is provided.
- the annuloplasty device 102 is adapted for permanent fixation at the mitral valve annulus by annuloplasty of the valve when the modified shape (A′) is obtained.
- the annuloplasty device 102 comprises a fixation structure 103 that is adapted to retain the modified shape (A′).
- annuloplasty device 102 having a fixation structure in the form of loop structures 103 such as a helix-shaped loop structure for positioning on either side of the MV to retain the modified shape (A′) of the annulus.
- the annuloplasty device 102 may be catheter deliverable, whereby it assumes an elongated shape when delivered trough a catheter and transferable to a looped structure when positioned at the MV.
- the annuloplasty device 102 is fixated at the annulus to retain the modified shape of the annulus and provide for closure of the dilated MV leaflets seen in FIG. 2 a .
- This fixation of the previously dilated MV leaflets by the annuloplasty device 102 is accordingly facilitated and improved by the temporary downsizing of the annulus into the modified shape (A′) by the displacement unit 101 , which is subsequently withdrawn from the CS as illustrated in FIG. 2 f .
- the medical system 100 therefore provides for efficient permanent fixation of defective MV leaflets via temporary modification or displacement of the MV geometry utilizing a removable displacement unit 101 in the CS and an annuloplasty device 102 for fixation of the temporary modification provided by the displacement unit 101 . Since the displacement unit 101 is temporarily and reversibly transferable to the activated state, it may again be reversed to the delivery state, and removed from the CS. Long term negative effects of implants in the CS or the need for repositioning or modification of a CS implant to ensure proper long-term function may thereby be avoided. Implants that are traumatic to the CS, both after short-term or long-term use is also avoided.
- the medical system 100 in combination provides the synergetic effect of providing efficient temporary downsizing with the displacement unit 101 and fixation of the downsized annulus with the annuloplasty device 102 in the long-term. Since the displacement unit 101 is temporarily provided in the CS the downsizing can be made in a much more robust and efficient manner compared to an implant, since the CS is only affected for short period of time while the annuloplasty device 102 is fixated at the annulus. Once the annuloplasty device 102 is fixated the displacement unit 101 may be reversed to its delivery state and removed from the CS.
- the fixation structure 103 may thus be adapted to retain the modified shape (A′) of the annulus in the delivery state of the displacement unit 101 after temporary activation in the activated state.
- FIG. 2 b illustrates the delivery state of the displacement unit 101
- FIG. 2 c shows the activated state of the latter where the displacement unit 101 has been radially expanded to provide the movement in the radial direction (r) and the temporary downsizing as explained above.
- FIG. 3 a illustrates the delivery state of the displacement unit 101
- FIG. 3 b shows the activated state of the latter where the displacement unit 101 has been folded, curved or bent in the radial direction (r) to provide movement of the annulus in the radial direction (r). This may provide for an improved downsizing as a greater portion of the annulus may be exerted to the force provided by the displacement unit 101 .
- At least a portion of the displacement unit may be reversibly movable to an activated shape [in said activated state] that at least partly assumes the curvature of said loop structure.
- the displacement unit 101 may thus have a shape in the activated state that is customized, adapted, or conformable to the shape of the annuloplasty implant 102 .
- part of the curvature of the displacement unit 101 in the activated state may be equal to the curvature of the loop structure of the annuloplasty implant 102 . It is thereby possible to obtain an efficient interplay and synergy between the functions of the displacement unit 101 and the annuloplasty implant 102 since the geometries are partly corresponding for an efficient downsizing into a modified shape of the annulus (A′) that can be fixated by the annuloplasty implant 102 having a corresponding shape.
- the displacement unit may comprise a lumen 105 the in the axial direction 106 of the displacement unit 101 , which is illustrated in FIGS. 4 a - b , FIGS. 5 a - b , and FIG. 6 . It may be desirable improve the blood flow in the CS while the displacement unit 101 is inserted in certain situations, hence the lumen may allow a blood flow there through.
- the lumen 105 may allow insertion of guide wires or the like through the displacement unit 101 , and further it may allow actuating units disposed in the interior of the displacement unit 101 to control the shape or size in any parts of the displacement unit 101 , to improve the control of the temporary downsizing procedure.
- the displacement unit 101 may comprise at least one inflatable unit 104 such as a balloon that is actively and reversibly expandable to a set shape.
- An inflatable unit 104 provided at a middle portion of the displacement unit that is positioned at the apex point 116 of the annulus curve, or having a length corresponding to the portion of the CS extending along annulus of the valve, provides for radial movement along this portion, by inflating the balloon. This can provide for a more efficient and improved downsizing effect than prior art devices where only the radius of curvature of the device is changed, or where a balloon is provided at a distal end point for the purpose of anchoring only.
- Control of the geometry of the displacement unit 101 is thereby provided, such that it can be transferred to the activated state in a controlled manner with a desired geometrical configuration as a set shape, and thereby achieve a desired form of the modified shape (A′) of the MV annulus.
- An arrangement of fluid ports may be disposed in the interior of the displacement unit 101 to its control inflation in a desired manner.
- the inflatable unit 104 may assume a preset curved shape in the activated state of the displacement unit 101 , such that it conforms more to the shape of the annulus. I.e.
- the displacement unit 101 may be actively folded, curved or bent into a shape with a further reduced radius of curvature when transferred into the activated shape, as discussed further below in relation to FIGS. 9 a - b , and FIGS. 11 a - c .
- the displacement unit 101 assumes a curved shape that is bending around the posterior side of the annulus, and as mentioned above, the displacement unit 101 may assume a preset curved shape in the activated state to further decrease the radius of curvature and improve the downsizing effect.
- the inflatable unit 104 may be asymmetrically expandable in the radial direction (r) of the CS.
- the cross-section of such inflatable unit 104 is illustrated in FIGS. 5 a - b , and FIGS. 8 a - b , where the radial portions of the inflatable unit 104 expand to different degrees, hence asymmetrically, in the activated state.
- the radial portion of the cross-section to the right in the figures assumes an increased cross-section in the activated state ( FIG. 5 b , FIG. 8 b ), whereas the left portion has not expanded or expanded to a lesser degree, see e.g. left portion 108 compared to right portion 104 in FIG.
- Asymmetric expansion may improve the downsizing effect in the radial direction (r) of the inflatable unit 104 that is positioned closest to the posterior side of the annulus, i.e. in the radial direction of the CS.
- the asymmetric expansion may be provided by having portions of the inflatable unit 104 of different material properties such as different expansion capabilities, or by arranging the inflatable unit 104 asymmetrically with respect to a center portion of the displacement unit 101 .
- a lumen 105 is arranged asymmetrically with respect to such center point 112 , i.e. rotational asymmetry, that may provide for a directed expansion of the inflatable unit 104 in a set direction such as in the radial direction of the CS.
- the inflatable unit 104 may assume a folded or curved shape when expanded in the activated state. As mentioned this may improve the downsizing further by exerting a force around the periphery of the MV at the annulus.
- the displacement unit may comprise a restraining member 107 that is arranged to restrict movement of the inflatable unit in at least one direction when expanded from the delivery state. The restraining member 107 may accordingly steer the shape of the displacement unit 101 even further by limiting expansion or folding in certain directions.
- the restraining member 107 may limit expansion at a first longitudinal side of the inflatable unit 104 so that during expansion of the inflatable unit 104 in the longitudinal direction 106 , a second side that may be opposite the first side, that is not restrained, will expand to a larger degree than the first side and the inflatable unit 104 will fold in the direction of the first side since these sides of the inflatable unit 104 will assume different lengths.
- FIG. 9 b shows folding in this manner, and in the radial direction of the CS.
- the restraining member 107 may thus be flexible, and may be affixed to various parts of the displacement unit 101 in order to achieve the desired shape, such as along a longitudinal side at with fixation means 113 .
- 11 a - c shows another example of the displacement unit 101 that may assume a folded or curved shape when expanded in the activated state by controlling movement of a first portion of the displacement unit 101 with a restraining member 107 , such that a second portion moves to a different extent, or along a different path, than the first portion.
- the at least one inflatable unit 104 may comprise a plurality of inflatable units wherein a first inflatable unit 104 and a second inflatable unit 108 are independently and reversibly inflatable.
- FIG. 10 a shows a displacement unit 101 that comprises first and second inflatable units 104 , 108 , that can be expanded independently and to different sizes in the activated state, as seen in FIG. 10 b . It is thereby possible to vary the force by which the displacement unit 101 exerts on the CS along the length of the displacement unit 101 to achieve a desired modification of the MV annulus and corresponding modification of the MV leaflets.
- the displacement unit 101 comprises first and second inflatable units 104 , 108 , along the radial direction (r) of the displacement unit 101 . It may thus be possible to control the amount of expansion in the radial direction and achieve asymmetric radial expansion as discussed above. Further, a passage 114 may be provided along the axial direction 106 between the first and second inflatable units 104 , 108 , as seen in FIG. 7 .
- FIGS. 11 a - c illustrates a displacement unit 101 having first and second inflatable units 104 , 108 , along the axial direction 106 , and a restraining member 107 at a first portion thereof for controlling movement in the activated state as explained above in relation to FIGS. 9 a - b .
- the displacement unit 101 may assume the shape illustrated in FIG. 11 b when in the delivery state and positioned in the CS adjacent the MV. In this state the first and second inflatable units 104 , 108 , have been displaced in relation to each other in order to easily conform to the CS anatomy.
- the first and second inflatable units 104 , 108 may be displaced at their joining ends 115 , or in another manner that allows adapting to the shape of the CS.
- the first and second inflatable units 104 , 108 have assumed an altered shape in the activated state. Due to the altered shape of each of the inflatable units 104 , 108 , they have been displaced in relation to each other at a second portion of the displacement unit 101 , that is not restrained by the restraining member 107 .
- the displacement unit 101 thereby exhibits a further modified shape in the activated state as the restraining member 107 limits movement of the inflatable units 104 , 108 , at a portion thereof. This may provide for improving the downsizing effect of the MV.
- the restraining member 107 may be arranged along a first side of the displacement unit 101 , attaching and joining each of the first and second inflatable units 104 , 108 , at a first side thereof, and the first and second inflatable units 104 , 108 , may each assumed an increased axial extension in the activated state such that they are axially displaced at their joining ends 115 . Such axial displacement may thus be restricted at the first side due to the fixation of the first and second inflatable units 104 , 108 , by the restraining member 107 . Unrestricted axial expansion at a second side, radially opposite the first side may thus provided for a further folded shape in the activated state.
- the displacement unit may comprise, at a radial portion thereof, at least one radiopaque marker 109 , 109 ′, for rotational alignment of the displacement unit in the CS, which is seen in FIG. 4 b , and further in FIGS. 5 a - b , 6 , 7 , 8 a - b.
- the displacement unit 101 may further comprise a support structure 110 arranged to support movement of the displacement unit 101 in the radial direction (r) and/or support a passageway 105 ′ through the displacement unit 101 in the axial direction 106 , as seen in FIG. 6 .
- the support structure may 110 be a framework or a braided structure.
- FIG. 12 A Method 200 for treating a defective mitral valve (V) having an annulus (A) according to one embodiment of the invention is illustrated in FIG. 12 .
- the method comprises inserting 201 a removable elongate displacement unit 101 , which may have any combination of the features described according to the disclosure as described above in relation to FIGS.
- FIG. 17 b show a medical system 300 for treating a defective mitral valve (MV) having an annulus (A).
- the system 300 comprises in combination a removable and flexible elongate displacement unit 301 for temporary insertion into a coronary sinus (CS) adjacent the valve, wherein the displacement unit has a delivery state ( FIG. 17 a ) for delivery into said CS, and an activated state to which the displacement unit is temporarily and reversibly transferable from the delivery state.
- CS coronary sinus
- the displacement unit comprises a proximal reversibly expandable portion 302 , a distal anchoring portion 303 being movable in relation to the proximal expandable portion in a longitudinal direction 304 of the displacement unit (so that the distance (L) between the two portions 302 , 303 , is reduced as seen in FIGS. 18 a - b ) to the activated state in which the shape of the annulus is modified to a modified shape (A′) ( FIG. 17 b ); and an annuloplasty device 102 for permanent fixation at the mitral valve annulus by annuloplasty of the valve when the modified shape is obtained ( FIG. 17 b ).
- the annuloplasty device 102 comprises a fixation structure 103 that is adapted to retain the modified shape.
- the radius of curvature of the CS and also the valve annulus can be reduced.
- the modified shape of the annulus is then fixated by the annuloplasty device 102 , before removing the displacement unit 101 .
- Previous prior art devices for insertion into the CS are for permanent implantation and are not adapted to be removed or used in conjunction with an annuloplasty device 102 .
- the prior art devices are focused bending of a segmented device only. The combination of reducing the length of the displacement unit 301 and having a proximal expandable portion 302 that efficiently provides a counter force against the anchoring portion 303 , greatly improves the downsizing effect.
- Both the proximal expandable portion 302 and the distal anchoring portion 303 are reversibly expandable for delivery and retrieval from a sheath 310 , see FIG. 13 c .
- the distal anchoring portion 303 and/or the proximal expandable portion 302 may pivot towards the longitudinal direction 304 in order to be easily retracted into the sheath 310 , see FIG. 13 b .
- FIGS. 15 and 16 shows the catheter with the displacement unit 101 at the distal end to be inserted into the CS. Another embodiment is shown in FIGS. 15 and 16 .
- the distal anchor is inserted and fixated into the CS and the proximal reversibly expandable portion 302 folds out from the sheath 310 to allow for performing the downsizing and is then folded back into the sheath 310 and is retracted.
- the fixation structure 102 is adapted to retain the modified shape of the annulus in the delivery state of the displacement unit after temporary activation in the activated state.
- the distance (L) between the proximal expandable portion 302 and the distal anchoring portion 303 in the longitudinal direction 304 decreases to a reduced distance (L′) when the displacement unit 301 is transferred from the delivery state to the activated state, see FIGS. 18 a - b . Since the distal anchoring portion 303 is fixated in the CS decreasing the distance between the proximal expandable portion 302 and the distal anchoring portion 303 will result in a reduced radius of curvature of the CS which will downsize the valve. Thus, the radius of curvature of the displacement unit 301 decreases when the displacement unit is transferred from the delivery state to the activated state.
- the proximal expandable portion 302 may be reversibly foldable to an expanded state for positioning against a tissue wall 305 at the entrance of the CS, as shown in FIG. 16 . This provides for a very stable fixation of the position of the proximal expandable portion 302 relative the distal anchor 303 for improved control of the downsizing of the valve. Since the proximal expandable portion 302 may be shaped and adapted for positioning against the tissue wall 305 at the entrance of the CS, and not inside the CS itself it also reduces the risk of damaging the CS.
- proximal expandable portion 302 is positioned outside the CS it is not constrained by the size of the CS and can thus be reversibly expanded to a diameter that spreads the force over a larger portion, thus reducing the pressure on the tissue. This also reduces risk of damages.
- the proximal expandable portion 302 may comprise expandable wire lobes 306 , 307 , for positioning against the tissue wall 305 at the entrance of the CS, see FIG. 15-16 .
- the wires lobes are adapted to be fixated against the tissue wall outside the CS, and provide for a stable fixation point.
- the wire lobes 306 , 307 may expand on either side of the sheath 310 to spread the force symmetrically for controlled positioning.
- Any expandable structure such as a balloon etc. may be provided as proximal expandable portion 302 for reversible expansion against the tissue wall 305 at the entrance of the CS, i.e. outside the CS to provide the above mentioned advantages.
- the proximal expandable portion 302 may have a larger expanded diameter than the distal anchoring portion 303 in the activated state of the displacement unit 301 . This is e.g. illustrated in FIG. 15 , and allows the proximal expandable portion 302 to be more securely positioned in relation to the anchor 303 for a more controlled downsizing.
- the distal anchoring portion 303 is expandable to anchor against said CS in the activated state of the displacement unit 301 . It provides sufficient force against the CS to be fixated relative the proximal expandable portion 302 when pulling the distal anchoring portion 303 towards the proximal expandable portion 302 .
- the distal anchoring portion 303 may comprise an expandable coiled wire 311 , see FIG. 15 .
- the coiled wire provides for efficient fixation against the CS, since pressure is provided evenly and circumferentially along the length of the coil, while at the same times allows to be easily retracted into the sheath 310 by extending the coil in the longitudinal direction 304 .
- the coiled wire may be connected to a control wire 308 , FIG. 15 , which is adapted to stretch the distal anchoring portion to a reduced diameter delivery shape, and reduce tension on the coiled wire in the activated state to expand the distal anchoring portion.
- the distal anchor in the CS by reducing the tension on the coil so that it can be retracted and expanded in diameter for fixation against the CS.
- the coil 311 provides for keeping the body lumen open so that blood flow can be maintained.
- the displacement unit 301 may comprise a delivery wire 309 , FIGS. 15 and 18 a - b , adapted to deliver the distal anchoring portion 303 and to pull the distal anchoring portion 303 towards the proximal expandable portion 302 in the activated state, whereby the distance (L) between the two is reduced to the shorter distance (L′), as illustrated in FIGS. 18 a - b , to provide the downsizing.
- the control wire 308 for the anchoring portion 303 may be pulled simultaneously and with the same displacement so that the anchoring portion maintains its length in the longitudinal direction 304 .
- the proximal expandable portion 303 may be reversibly foldable to an expanded state where the proximal expandable portion 303 has a diameter substantially larger than the diameter of the CS. This allows for a more stable fixation outside the CS with the advantages mentioned above.
- the anchoring portion may comprise a tissue retention portion such as at least one hook 312 , 312 ′, as illustrated in FIGS. 19 a - b .
- the tissue retention portion 312 , 312 ′ provides for efficient fixation of the anchoring portion 303 inside the CS, that allow for efficient downsizing of the valve annulus.
- FIG. 19 b illustrates the case when to retention portions 312 , 312 ′, are employed, but any number of retention portions can be used, to optimize the efficiency of the procedure.
- other retention members grasping the tissue can be provided.
- the retention portions 312 , 312 ′ are preferably oriented towards the myocardial wall of the CS which is more robust for grasping of the retention portions 312 , 312 ′.
- the anchoring portion 303 may comprise a tissue apposition portion 313 having a tissue atraumatic surface, such as an at least partly curved or spherical surface.
- the tissue apposition portion 313 provides for exerting a counter force against the wall of the CS, stabilizing the anchoring portion 303 , and allowing for the retention portion 312 , 312 ′, to more efficiently grasp the tissue and anchor against the same. Also, it helps keeping the CS vein open for sustaining a flow of blood, in addition to the coil 311 which also keeps the CS vein open.
- FIGS. 19 a - b illustrates a spherical surface of the apposition portion, but it may have surface that lies smooth against the CS.
- the tissue retention portion 312 , 312 ′ is expandable in a direction substantially perpendicular to the longitudinal direction 304 . It may therefore efficiently engage the wall of the CS.
- the retention portion 312 , 312 ′ can be formed of a metal alloy having a heat set shape where it assumes an outwardly curved shape as illustrated in FIGS. 19 a - b , for engaging the tissue.
- the retention portion 312 , 312 ′ may be connected to the delivery wire 309 , such that when the delivery wire is pulled back relative the proximal expandable portion 302 , the retention portion 312 , 312 ′, grasp the tissue, anchors the anchoring portion 303 , and draw the tissue against the proximal expandable portion 302 to achieve the reduced length (L′) and the downsizing effect.
- the retention portion 312 , 312 ′ may be connected to a separate control wire (not shown) so that the radially outward expansion of the retention portion 312 , 312 ′, can be controlled independently of the position of the delivery wire 309 .
- the retention portion 312 , 312 ′ may first be retracted, e.g. within the coil 311 , before pushed in the longitudinal direction 304 , where it may assume the heat set radially expanded shape for grasping the tissue as discussed.
- the tissue apposition portion 313 may be controlled and deployed in the same manner as described in the preceding paragraph for the retention portion 312 , 312 ′, e.g. being connected to delivery wire 309 or a separate control wire (not shown), such that the tissue apposition portion can be expandable in a direction substantially perpendicular to the longitudinal direction 304 for contacting the all of the CS.
- the tissue retention portion and said tissue apposition portion may be expandable in substantially opposite directions, as illustrated in FIGS. 19 a - b .
- This allows the tissue apposition portion 313 to provide a good counter force relative the retention portion 312 , 312 ′, for efficient grasping of the tissue and secure anchoring.
- the retention portion 312 , 312 ′ is directed to the stronger myocardial wall, the tissue apposition portion 313 is placed against the more sensitive side of the CS.
- the displacement unit may comprise, at a radial portion thereof, at least one radiopaque marker 109 for rotational alignment of the displacement unit in the CS.
- the tissue apposition portion 313 may have a radiopaque marker 109 for assisting in orienting away from the myocardial wall.
- the retention portion 312 , 312 ′ may comprise a radiopaque marker 109 .
- FIG. 20 illustrates a method 400 for treating a defective mitral valve (V) having an annulus (A) comprising; inserting 401 a flexible and removable elongate displacement unit 301 in a delivery state into a coronary sinus (CS) adjacent the valve, positioning 402 a proximal expandable portion 302 against a tissue wall 305 at the entrance of the CS, positioning 403 a distal anchoring portion 303 inside the CS, activating 404 the displacement unit in an activated state whereby the distal anchoring portion is moved in a longitudinal direction 304 of the displacement unit to reduce the distance between the distal anchoring portion and the proximal expandable portion such that the shape of the annulus is modified to a modified shape (A′), fixating 405 an annuloplasty device 102 at the mitral valve annulus when the modified shape is obtained, whereby the annuloplasty device comprises a fixation structure 103 that is adapted to retain the modified shape, removing 406 the elongate displacement unit after temporary activation in the activated state.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Reproductive Health (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Prostheses (AREA)
Abstract
A medical system is disclosed for treating a defective mitral valve (MV) having an annulus (A). The system has a removable and flexible elongate displacement unit for temporary insertion into a coronary sinus (CS) adjacent the valve, wherein the displacement unit has a delivery state for delivery into said CS, and an activated state to which the displacement unit is temporarily and reversibly transferable from the delivery state. The displacement unit has a proximal reversibly expandable portion, a distal anchoring portion being movable in relation to the proximal expandable portion in a longitudinal direction of the displacement unit to the activated state in which the shape of the annulus is modified to a modified shape (A′); and an annuloplasty device for permanent fixation at the mitral valve annulus by annuloplasty of the valve when the modified shape is obtained.
Description
- This application is a continuation of U.S. patent application Ser. No. 14/891,939 filed Nov. 17, 2015 entitled Medical System For Annuloplasty, which is the U.S. National Phase of and claims priority to International Patent Application No. PCT/EP2014/060434, International Filing Date May 21, 2014, entitled Medical System For Annuloplasty, which claims benefit of European Patent Application No. EP13168600.8, filed May 21, 2013 entitled Medical System For Annuloplasty, all of which are incorporated herein by reference in their entireties.
- This invention pertains in general to the field of annuloplasty devices for treating a defective mitral valve. More particularly the invention relates to a medical system of devices for treating a defective mitral valve via coronary sinus and an annuloplasty implant for fixation of the annulus, and a method therefor.
- Diseased mitral valves frequently need repair to function properly. The mitral valve leaflets or supporting chordae may degenerate and weaken or the annulus may dilate leading to valve leak (valve insufficiency). Mitral valve repair is frequently performed with aid of an annuloplasty ring, used to reduce the diameter of the annulus, or modify the geometry of the annulus in any other way, or aid as a generally supporting structure during the valve replacement or repair procedure.
- Implants have previously been introduced into the coronary sinus (CS) in order to affect the shape of the valve annulus and thereby the valve function. U.S. Pat. No. 6,210,432 and WO02/062270 discloses such implant that is aimed to replace annuloplasty rings. Permanent implant have several disadvantageous effects, for example since they are implanted into the CS which is a source for later complications.
- Thus, a problem with the prior art implants in the CS is that such implants may be less effective in retaining the desired geometry of the annulus. It may be necessary for the implants to be positioned in the CS for a lengthy time in order to sustain the correct function of the valve. This pose significant requirements on the long-term function of the implant, that may not implants as effective as annuloplasty rings to start with. A further problem with prior art is thus that complex and difficult-to-operate devices must be deployed in the CS, that may require frequent adjustment and repositioning to ensure the correct function over time. Another problem with prior art devices is the traumatic effects on the CS itself, due to fixation structures that must ensure the correct position of the device in the CS over time. Another problem is to ensure that a significant part of the annulus is reshaped while providing for atraumatic engagement with the anatomy.
- EP2072027 discloses a device for insertion into the CS. It is a segmented device that can change its radius. A balloon at the distal end for providing a temporary fixation point at the distal end is disclosed.
- US 2007/185572A1 discloses an implant for treating a mitral valve, comprising an elongate member having a spiral shape, the elongate member having a proximal end portion and a distal end portion, an expandable proximal anchor joined to the proximal end portion of the elongate body, and an expandable distal anchor joined to the distal end portion of the elongate body. The elongate member is configured to adjust from an elongated state to a shortened state after delivery into a coronary sinus for reshaping a mitral annulus.
- WO 2004/084746A2 discloses a device for treatment of insufficiency of a heart valve comprising a longitudinal body that can have at least two different forms, namely one easily introduced into the coronary sinus or the great cardiac vein and to the vessel adaptable form, and a second one the position of the heart valve affecting form. The second form, when the longitudinal body has been placed into the said vein, presses the vessel and thereby the orifice of the heart valve in parallel towards a closed position.
- US 2008/103590A1 discloses a CS device having a coil, which is disposed between straight sections and a tether for adjusting the stiffness of a spring and the relative force applied by the device against the adjacent tissue and mitral valve annulus. The mitral valve annulus reshaping device includes a distal stent and a proximal stent that are also preferably formed of SMA. Distal stent is allowed to expand as it converts from UM toward its austenitic state once the constraint of the catheter is removed.
- US 2004/153147A1 discloses a method and device for reducing mitral regurgitation. An elongated body is positioned in a coronary sinus of a patient in a vicinity of a heart mitral valve posterior leaflet. The body is adapted to straighten a natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet to move a posterior annulus anteriorly, which in turn moves the posterior leaflet anteriorly, thereby to improve leaflet coaptation.
- The above problems may have dire consequences for the patient and the health care system. Patient risk is increased.
- Hence, an improved medical system for performing downsizing and reshaping of the valve annulus would be advantageous and in particular allowing for ensuring long-term functioning, less complex procedure, and less traumatic effects on the anatomy and increased patient safety.
- Also, a method of downsizing and reshaping the mitral valve annulus with such medical system would be advantageous.
- Accordingly, embodiments of the present invention preferably seeks to mitigate, alleviate or eliminate one or more deficiencies, disadvantages or issues in the art, such as the above-identified, singly or in any combination by providing a device according to the appended patent claims.
- According to a first aspect of the invention a medical system for treating a defective mitral valve (MV) having an annulus (A) is provided. The system comprises in combination a removable and flexible elongate displacement unit for temporary insertion into a coronary sinus (CS) adjacent the valve, wherein the displacement unit has a delivery state for delivery into said CS, and an activated state to which the displacement unit is temporarily and reversibly transferable from the delivery state. The displacement unit comprises a proximal reversibly expandable portion, a distal anchoring portion being movable in relation to the proximal expandable portion in a longitudinal direction of the displacement unit to the activated state in which the shape of the annulus is modified to a modified shape (A′); and an annuloplasty device for permanent fixation at the mitral valve annulus by annuloplasty of the valve when the modified shape is obtained. The annuloplasty device comprises a fixation structure that is adapted to retain the modified shape. According to a second aspect of the invention a method is provided for treating a defective mitral valve having an annulus, where the method comprises; inserting a flexible and removable elongate displacement unit in a delivery state into a coronary sinus (CS) adjacent said valve, positioning a proximal expandable portion against a tissue wall at the entrance of said CS, positioning a distal anchoring portion inside said CS, activating said displacement unit in an activated state whereby said distal anchoring portion is moved in a longitudinal direction of said displacement unit to reduce the distance (L) between said distal anchoring portion and said proximal expandable portion, to a shorter or reduced distance (L′) such that the shape of the annulus is modified to a modified shape (A′), fixating an annuloplasty device at the mitral valve annulus when said modified shape is obtained, whereby said annuloplasty device comprises a fixation structure that is adapted to retain said modified shape, removing said elongate displacement unit after temporary activation in the activated state.
- According to a third aspect of the invention a removable and flexible elongate displacement unit for temporary insertion into a coronary sinus (CS) adjacent a defective mitral valve (MV) having an annulus (A) is disclosed. The displacement unit has a delivery state for delivery into said CS, and an activated state to which the displacement unit is temporarily and reversibly transferable from said delivery state. The displacement unit comprises a proximal reversibly expandable portion, a distal anchoring portion being movable in relation to said proximal expandable portion in a longitudinal direction of said displacement unit to said activated state in which the shape of the annulus is modified to a modified shape (A′).
- According to a fourth aspect of the invention a medical system for treating a defective mitral valve having an annulus is provided, where the medical system comprises in combination; a removable elongate displacement unit for temporary insertion into a coronary sinus (CS) adjacent the mitral valve, wherein the displacement unit has a delivery state for delivery into the CS, and an activated state to which the displacement unit is temporarily and reversibly transferable from the delivery state, whereby at least a portion of the displacement unit is temporarily movable in a radial direction of the CS towards the valve in such a manner that the shape of the annulus is modified to a modified shape. The medical system further comprising an annuloplasty device for permanent fixation at the mitral valve annulus by annuloplasty of the valve when the modified shape is obtained, wherein the annuloplasty device comprises a fixation structure that is adapted to retain the modified shape.
- According to a fifth aspect of the invention a method is provided for treating a defective mitral valve having an annulus, where the method comprises; inserting a removable elongate displacement unit in a delivery state into a coronary sinus (CS) adjacent the mitral valve; activating the displacement unit in an activated state whereby at least a portion of the displacement unit is moved in a radial direction of the CS towards the valve in such a manner that the shape of the annulus is modified to a modified shape; fixating an annuloplasty device at the mitral valve annulus when then modified shape is obtained, whereby the annuloplasty device comprises a fixation structure that is adapted to retain the modified shape; and removing the elongate displacement unit after temporary activation in the activated state.
- Further embodiments of the invention are defined in the dependent claims, wherein features for the second and subsequent aspects of the invention are as for the first aspect mutatis mutandis. In particular, features of the first aspect of the invention as defined in the dependent claims to the first aspect of the invention are also applied to the third aspect of the invention.
- Some embodiments of the invention provide for long-term functioning of the mitral valve.
- Some embodiments of the invention provide for less complex downsizing procedures of the mitral valve.
- Some embodiments of the invention provide for a reduced risk of damaging the anatomy such as the CS.
- Some embodiments of the invention provide for a secure downsizing while at the same time reducing the risk of damaging the anatomy such as the CS.
- Some embodiments of the invention provide for improved downsizing of the mitral valve annulus while ensuring an atraumatic procedure.
- Some embodiments of the invention also provide for reduced risk of long-term negative effects of CS implants.
- It should be emphasized that the term “comprises/comprising” when used in this specification is taken to specify the presence of stated features, integers, steps or components but does not preclude the presence or addition of one or more other features, integers, steps, components or groups thereof.
- These and other aspects, features and advantages of which embodiments of the invention are capable of will be apparent and elucidated from the following description of embodiments of the present invention, reference being made to the accompanying drawings, in which
-
FIG. 1 is an illustration of the heart showing the coronary sinus in relation to the mitral valve in a side-view; -
FIG. 2a is an illustration of the heart showing the coronary sinus in relation to a diseased mitral valve in a top-down view; -
FIG. 2b is an illustration of a part of a medical system according to embodiments of the invention in a first state; -
FIG. 2c is an illustration of a part of a medical system according to embodiments of the invention in a second state; -
FIG. 2d is an illustration of a medical system according to embodiments of the invention; -
FIG. 2e is an illustration of a part of a medical system according to embodiments of the invention; -
FIG. 2f is an illustration of a part of a medical system according to embodiments of the invention; -
FIG. 3a is an illustration of a part of a medical system according to embodiments of the invention in a first state; -
FIG. 3b is an illustration of a medical system according to embodiments of the invention; -
FIG. 4a is an illustration of a part of a medical system according to embodiments of the invention in a perspective view; -
FIG. 4b is an illustration of a medical system according to embodiments of the invention in a perspective view; -
FIGS. 5a-b are illustrations of a part of a medical system according to embodiments of the invention in a side views; -
FIG. 6 is an illustration of a part of a medical system according to an embodiment of the invention in a side view; -
FIG. 7 is an illustration of a part of a medical system according to an embodiment of the invention in a side view; -
FIGS. 8a-b are illustrations of a part of a medical system according to embodiments of the invention in a side views; -
FIGS. 9a-b are illustrations of a part of a medical system according to embodiments of the invention in a top-down view; -
FIGS. 10a-b are illustrations of a part of a medical system according to embodiments of the invention in a top-down view; -
FIGS. 11a-c are illustrations of a part of a medical system according to embodiments of the invention in a top-down view; -
FIG. 12 is a flow chart illustrating a method of treating a defective mitral valve according to embodiments of the invention; -
FIGS. 13a-c are illustrations of a displacement unit according to embodiments of the invention, also being part of a medical system according to embodiments of the invention; -
FIGS. 14a-b are illustrations of a displacement unit according to embodiments of the invention, also being part of a medical system according to embodiments of the invention; -
FIG. 15 is an illustration of a displacement unit according to embodiments of the invention, also being part of a medical system according to embodiments of the invention; -
FIG. 16 is an illustration of a displacement unit according to embodiments of the invention, in use, also being part of a medical system according to embodiments of the invention; -
FIG. 17a is an illustration of a displacement unit according to embodiments of the invention, also being part of a medical system according to embodiments of the invention; -
FIG. 17b is an illustration of a medical system according to embodiments of the invention; -
FIGS. 18a-b are illustrations of a displacement unit according to embodiments of the invention, also being part of a medical system according to embodiments of the invention; -
FIGS. 19a-b are illustrations of a displacement unit according to embodiments of the invention, also being part of a medical system according to embodiments of the invention; -
FIG. 20 is a flow chart illustrating a method of treating a defective mitral valve according to embodiments of the invention. - Specific embodiments of the invention will now be described with reference to the accompanying drawings. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. The terminology used in the detailed description of the embodiments illustrated in the accompanying drawings is not intended to be limiting of the invention. In the drawings, like numbers refer to like elements.
- The following description focuses on an embodiment of the present invention applicable to treatment of defective mitral valves by repairing of the native valve. However, it will be appreciated that the invention is not limited to this application but may be applied to many other annuloplasty procedures including for example replacement valves, and other medical implantable devices.
-
FIG. 1 is an illustration of the heart showing the coronary sinus (CS) in relation to the mitral valve (MV) in a side-view. The CS lies adjacent the MV and follows a curvature around the annulus (A) of the MV, which is further illustrated in the top-down view ofFIG. 2 a. -
FIG. 2d shows amedical system 100 for treating a defective mitral valve (MV) having an annulus (A) according to an embodiment of the invention. The system comprises in combination a removableelongate displacement unit 101 and aannuloplasty device 102 for permanent fixation at the mitral valve. Thedisplacement unit 101 is adapted for temporary insertion into the CS adjacent the MV, and it has a delivery state for delivery into the CS. In the delivery state, thedisplacement unit 101 is bendable in an arch shape at a portion of thedisplacement unit 101 upon said delivery, i.e. as it is positioned in the CS, and can therefore adapt to the anatomy of the CS and conform to the curvature of the CS adjacent a dilated MV, which is illustrated inFIG. 2b . As thedisplacement unit 101 is removable and adapted for temporary insertion in the CS, it may be permanently attached to adelivery unit 111, such as a delivery wire, guide wire or the like. Thedisplacement unit 101 has further an activated state to which the displacement unit is temporarily and reversibly transferable from the delivery state. Thus, at least a portion of thedisplacement unit 101 is temporarily movable in a radial direction (r) of the CS towards the MV in such a manner that the shape of the annulus (A) is modified to a modified shape (A′), as thedisplacement unit 101 is transferred its activated state, which is illustrated inFIG. 2c . As the displacement unit is being able to move in the radial direction, efficient downsizing of the valve annulus is provided. Substantially the entire length of the displacement unit may be able to move in the radial direction. Alternatively, a portion such as a middle portion of the displacement unit positionable at theapex point 116 of the annulus curve is movable in the radial direction. This can provide for a more efficient and improved downsizing effect than prior art devices where only the radius of curvature of the device is changed. Theannuloplasty device 102 is adapted for permanent fixation at the mitral valve annulus by annuloplasty of the valve when the modified shape (A′) is obtained. Hence, theannuloplasty device 102 comprises afixation structure 103 that is adapted to retain the modified shape (A′).FIG. 2e shows an example ofsuch annuloplasty device 102, having a fixation structure in the form ofloop structures 103 such as a helix-shaped loop structure for positioning on either side of the MV to retain the modified shape (A′) of the annulus. Theannuloplasty device 102 may be catheter deliverable, whereby it assumes an elongated shape when delivered trough a catheter and transferable to a looped structure when positioned at the MV. - At least a portion of the
loop structure 103 conforms to the curvature of the annulus. InFIG. 2d theannuloplasty device 102 is fixated at the annulus to retain the modified shape of the annulus and provide for closure of the dilated MV leaflets seen inFIG. 2a . This fixation of the previously dilated MV leaflets by theannuloplasty device 102 is accordingly facilitated and improved by the temporary downsizing of the annulus into the modified shape (A′) by thedisplacement unit 101, which is subsequently withdrawn from the CS as illustrated inFIG. 2f . Themedical system 100 therefore provides for efficient permanent fixation of defective MV leaflets via temporary modification or displacement of the MV geometry utilizing aremovable displacement unit 101 in the CS and anannuloplasty device 102 for fixation of the temporary modification provided by thedisplacement unit 101. Since thedisplacement unit 101 is temporarily and reversibly transferable to the activated state, it may again be reversed to the delivery state, and removed from the CS. Long term negative effects of implants in the CS or the need for repositioning or modification of a CS implant to ensure proper long-term function may thereby be avoided. Implants that are traumatic to the CS, both after short-term or long-term use is also avoided. Themedical system 100 in combination provides the synergetic effect of providing efficient temporary downsizing with thedisplacement unit 101 and fixation of the downsized annulus with theannuloplasty device 102 in the long-term. Since thedisplacement unit 101 is temporarily provided in the CS the downsizing can be made in a much more robust and efficient manner compared to an implant, since the CS is only affected for short period of time while theannuloplasty device 102 is fixated at the annulus. Once theannuloplasty device 102 is fixated thedisplacement unit 101 may be reversed to its delivery state and removed from the CS. - Hence, the
fixation structure 103 may thus be adapted to retain the modified shape (A′) of the annulus in the delivery state of thedisplacement unit 101 after temporary activation in the activated state. - At least a portion of the
displacement unit 101 may be reversibly expandable in the radial direction (r) in the activated state.FIG. 2b illustrates the delivery state of thedisplacement unit 101 andFIG. 2c shows the activated state of the latter where thedisplacement unit 101 has been radially expanded to provide the movement in the radial direction (r) and the temporary downsizing as explained above. - Alternatively, or in addition, at least a portion of the
displacement unit 101 may be reversibly foldable in the radial direction (r) in the activated state.FIG. 3a illustrates the delivery state of thedisplacement unit 101 andFIG. 3b shows the activated state of the latter where thedisplacement unit 101 has been folded, curved or bent in the radial direction (r) to provide movement of the annulus in the radial direction (r). This may provide for an improved downsizing as a greater portion of the annulus may be exerted to the force provided by thedisplacement unit 101. - At least a portion of the displacement unit may be reversibly movable to an activated shape [in said activated state] that at least partly assumes the curvature of said loop structure.
- The
displacement unit 101 may thus have a shape in the activated state that is customized, adapted, or conformable to the shape of theannuloplasty implant 102. For example, part of the curvature of thedisplacement unit 101 in the activated state may be equal to the curvature of the loop structure of theannuloplasty implant 102. It is thereby possible to obtain an efficient interplay and synergy between the functions of thedisplacement unit 101 and theannuloplasty implant 102 since the geometries are partly corresponding for an efficient downsizing into a modified shape of the annulus (A′) that can be fixated by theannuloplasty implant 102 having a corresponding shape. - The displacement unit may comprise a
lumen 105 the in theaxial direction 106 of thedisplacement unit 101, which is illustrated inFIGS. 4a-b ,FIGS. 5a-b , andFIG. 6 . It may be desirable improve the blood flow in the CS while thedisplacement unit 101 is inserted in certain situations, hence the lumen may allow a blood flow there through. Thelumen 105 may allow insertion of guide wires or the like through thedisplacement unit 101, and further it may allow actuating units disposed in the interior of thedisplacement unit 101 to control the shape or size in any parts of thedisplacement unit 101, to improve the control of the temporary downsizing procedure. - The
displacement unit 101 may comprise at least oneinflatable unit 104 such as a balloon that is actively and reversibly expandable to a set shape. Aninflatable unit 104 provided at a middle portion of the displacement unit that is positioned at theapex point 116 of the annulus curve, or having a length corresponding to the portion of the CS extending along annulus of the valve, provides for radial movement along this portion, by inflating the balloon. This can provide for a more efficient and improved downsizing effect than prior art devices where only the radius of curvature of the device is changed, or where a balloon is provided at a distal end point for the purpose of anchoring only. Control of the geometry of thedisplacement unit 101 is thereby provided, such that it can be transferred to the activated state in a controlled manner with a desired geometrical configuration as a set shape, and thereby achieve a desired form of the modified shape (A′) of the MV annulus. An arrangement of fluid ports (not shown) may be disposed in the interior of thedisplacement unit 101 to its control inflation in a desired manner. For instance, theinflatable unit 104 may assume a preset curved shape in the activated state of thedisplacement unit 101, such that it conforms more to the shape of the annulus. I.e. besides the bendable properties of thedisplacement unit 101 when inserted in the CS in the delivery state, it may be actively folded, curved or bent into a shape with a further reduced radius of curvature when transferred into the activated shape, as discussed further below in relation toFIGS. 9a-b , andFIGS. 11a-c . Further, as seen inFIG. 4b thedisplacement unit 101 assumes a curved shape that is bending around the posterior side of the annulus, and as mentioned above, thedisplacement unit 101 may assume a preset curved shape in the activated state to further decrease the radius of curvature and improve the downsizing effect. - The
inflatable unit 104 may be asymmetrically expandable in the radial direction (r) of the CS. The cross-section of suchinflatable unit 104 is illustrated inFIGS. 5a-b , andFIGS. 8a-b , where the radial portions of theinflatable unit 104 expand to different degrees, hence asymmetrically, in the activated state. For instance, the radial portion of the cross-section to the right in the figures, assumes an increased cross-section in the activated state (FIG. 5b ,FIG. 8b ), whereas the left portion has not expanded or expanded to a lesser degree, see e.g.left portion 108 compared toright portion 104 inFIG. 8b in the activated state versus the delivery state (FIG. 8a ). Asymmetric expansion may improve the downsizing effect in the radial direction (r) of theinflatable unit 104 that is positioned closest to the posterior side of the annulus, i.e. in the radial direction of the CS. The asymmetric expansion may be provided by having portions of theinflatable unit 104 of different material properties such as different expansion capabilities, or by arranging theinflatable unit 104 asymmetrically with respect to a center portion of thedisplacement unit 101. InFIGS. 5a-b alumen 105 is arranged asymmetrically with respect tosuch center point 112, i.e. rotational asymmetry, that may provide for a directed expansion of theinflatable unit 104 in a set direction such as in the radial direction of the CS. - Reference is now made to
FIGS. 9a-b . Theinflatable unit 104 may assume a folded or curved shape when expanded in the activated state. As mentioned this may improve the downsizing further by exerting a force around the periphery of the MV at the annulus. In addition, or alternatively to having theinflatable unit 104 to assume a preset shape when expanded the displacement unit may comprise a restrainingmember 107 that is arranged to restrict movement of the inflatable unit in at least one direction when expanded from the delivery state. The restrainingmember 107 may accordingly steer the shape of thedisplacement unit 101 even further by limiting expansion or folding in certain directions. For instance, the restrainingmember 107 may limit expansion at a first longitudinal side of theinflatable unit 104 so that during expansion of theinflatable unit 104 in thelongitudinal direction 106, a second side that may be opposite the first side, that is not restrained, will expand to a larger degree than the first side and theinflatable unit 104 will fold in the direction of the first side since these sides of theinflatable unit 104 will assume different lengths.FIG. 9b shows folding in this manner, and in the radial direction of the CS. The restrainingmember 107 may thus be flexible, and may be affixed to various parts of thedisplacement unit 101 in order to achieve the desired shape, such as along a longitudinal side at with fixation means 113.FIGS. 11a-c shows another example of thedisplacement unit 101 that may assume a folded or curved shape when expanded in the activated state by controlling movement of a first portion of thedisplacement unit 101 with a restrainingmember 107, such that a second portion moves to a different extent, or along a different path, than the first portion. - The at least one
inflatable unit 104 may comprise a plurality of inflatable units wherein a firstinflatable unit 104 and a secondinflatable unit 108 are independently and reversibly inflatable.FIG. 10a shows adisplacement unit 101 that comprises first and secondinflatable units FIG. 10b . It is thereby possible to vary the force by which thedisplacement unit 101 exerts on the CS along the length of thedisplacement unit 101 to achieve a desired modification of the MV annulus and corresponding modification of the MV leaflets.FIG. 7 andFIGS. 8a-b illustrate embodiments where thedisplacement unit 101 comprises first and secondinflatable units displacement unit 101. It may thus be possible to control the amount of expansion in the radial direction and achieve asymmetric radial expansion as discussed above. Further, apassage 114 may be provided along theaxial direction 106 between the first and secondinflatable units FIG. 7 . -
FIGS. 11a-c illustrates adisplacement unit 101 having first and secondinflatable units axial direction 106, and a restrainingmember 107 at a first portion thereof for controlling movement in the activated state as explained above in relation toFIGS. 9a-b . Thedisplacement unit 101 may assume the shape illustrated inFIG. 11b when in the delivery state and positioned in the CS adjacent the MV. In this state the first and secondinflatable units inflatable units ends 115, or in another manner that allows adapting to the shape of the CS. InFIG. 11c the first and secondinflatable units inflatable units displacement unit 101, that is not restrained by the restrainingmember 107. Thedisplacement unit 101 thereby exhibits a further modified shape in the activated state as the restrainingmember 107 limits movement of theinflatable units member 107 may be arranged along a first side of thedisplacement unit 101, attaching and joining each of the first and secondinflatable units inflatable units inflatable units member 107. Unrestricted axial expansion at a second side, radially opposite the first side may thus provided for a further folded shape in the activated state. - The displacement unit may comprise, at a radial portion thereof, at least one
radiopaque marker FIG. 4b , and further inFIGS. 5a-b , 6, 7, 8 a-b. - The
displacement unit 101 may further comprise asupport structure 110 arranged to support movement of thedisplacement unit 101 in the radial direction (r) and/or support apassageway 105′ through thedisplacement unit 101 in theaxial direction 106, as seen inFIG. 6 . The support structure may 110 be a framework or a braided structure. - A
Method 200 for treating a defective mitral valve (V) having an annulus (A) according to one embodiment of the invention is illustrated inFIG. 12 . The method comprises inserting 201 a removableelongate displacement unit 101, which may have any combination of the features described according to the disclosure as described above in relation toFIGS. 1-11 , in a delivery state into a coronary sinus (CS) adjacent the valve; activating 202 thedisplacement unit 101 in an activated state whereby at least a portion of thedisplacement unit 101 is moved in a radial direction (r) of the CS towards the valve in such a manner that the shape of the annulus is modified to a modified shape (A′); fixating 203 anannuloplasty device 102 at the mitral valve annulus when the modified shape is obtained, whereby theannuloplasty device 102 comprises afixation structure 103 that is adapted to retain the modified shape; and removing 204 theelongate displacement unit 101 after temporary activation in the activated state. -
FIG. 17b show amedical system 300 for treating a defective mitral valve (MV) having an annulus (A). Thesystem 300 comprises in combination a removable and flexibleelongate displacement unit 301 for temporary insertion into a coronary sinus (CS) adjacent the valve, wherein the displacement unit has a delivery state (FIG. 17a ) for delivery into said CS, and an activated state to which the displacement unit is temporarily and reversibly transferable from the delivery state. The displacement unit comprises a proximal reversiblyexpandable portion 302, adistal anchoring portion 303 being movable in relation to the proximal expandable portion in alongitudinal direction 304 of the displacement unit (so that the distance (L) between the twoportions FIGS. 18a-b ) to the activated state in which the shape of the annulus is modified to a modified shape (A′) (FIG. 17b ); and anannuloplasty device 102 for permanent fixation at the mitral valve annulus by annuloplasty of the valve when the modified shape is obtained (FIG. 17b ). Theannuloplasty device 102 comprises afixation structure 103 that is adapted to retain the modified shape. By moving thedistal anchoring portion 303 in the longitudinal direction towards the proximalexpandable portion 302 the radius of curvature of the CS and also the valve annulus can be reduced. The modified shape of the annulus is then fixated by theannuloplasty device 102, before removing thedisplacement unit 101. Previous prior art devices for insertion into the CS are for permanent implantation and are not adapted to be removed or used in conjunction with anannuloplasty device 102. Alternatively, the prior art devices are focused bending of a segmented device only. The combination of reducing the length of thedisplacement unit 301 and having a proximalexpandable portion 302 that efficiently provides a counter force against the anchoringportion 303, greatly improves the downsizing effect. Absence of a proximal expandable portion will make the downsizing considerably more difficult. Thesystem 300 allows for improved efficiency treating diseased valves due to efficient downsizing of the valve via the CS and subsequent fixation of the annulus at the valve itself. Both the proximalexpandable portion 302 and thedistal anchoring portion 303 are reversibly expandable for delivery and retrieval from asheath 310, seeFIG. 13c . In one embodiment thedistal anchoring portion 303 and/or the proximalexpandable portion 302 may pivot towards thelongitudinal direction 304 in order to be easily retracted into thesheath 310, seeFIG. 13b .FIGS. 14a-b shows the catheter with thedisplacement unit 101 at the distal end to be inserted into the CS. Another embodiment is shown inFIGS. 15 and 16 . The distal anchor is inserted and fixated into the CS and the proximal reversiblyexpandable portion 302 folds out from thesheath 310 to allow for performing the downsizing and is then folded back into thesheath 310 and is retracted. - The
fixation structure 102 is adapted to retain the modified shape of the annulus in the delivery state of the displacement unit after temporary activation in the activated state. - The distance (L) between the proximal
expandable portion 302 and thedistal anchoring portion 303 in thelongitudinal direction 304 decreases to a reduced distance (L′) when thedisplacement unit 301 is transferred from the delivery state to the activated state, seeFIGS. 18a-b . Since thedistal anchoring portion 303 is fixated in the CS decreasing the distance between the proximalexpandable portion 302 and thedistal anchoring portion 303 will result in a reduced radius of curvature of the CS which will downsize the valve. Thus, the radius of curvature of thedisplacement unit 301 decreases when the displacement unit is transferred from the delivery state to the activated state. - The proximal
expandable portion 302 may be reversibly foldable to an expanded state for positioning against atissue wall 305 at the entrance of the CS, as shown inFIG. 16 . This provides for a very stable fixation of the position of the proximalexpandable portion 302 relative thedistal anchor 303 for improved control of the downsizing of the valve. Since the proximalexpandable portion 302 may be shaped and adapted for positioning against thetissue wall 305 at the entrance of the CS, and not inside the CS itself it also reduces the risk of damaging the CS. Also, since the proximalexpandable portion 302 is positioned outside the CS it is not constrained by the size of the CS and can thus be reversibly expanded to a diameter that spreads the force over a larger portion, thus reducing the pressure on the tissue. This also reduces risk of damages. - The proximal
expandable portion 302 may compriseexpandable wire lobes tissue wall 305 at the entrance of the CS, seeFIG. 15-16 . The wires lobes are adapted to be fixated against the tissue wall outside the CS, and provide for a stable fixation point. Thewire lobes sheath 310 to spread the force symmetrically for controlled positioning. Any expandable structure such as a balloon etc. may be provided as proximalexpandable portion 302 for reversible expansion against thetissue wall 305 at the entrance of the CS, i.e. outside the CS to provide the above mentioned advantages. - The proximal
expandable portion 302 may have a larger expanded diameter than thedistal anchoring portion 303 in the activated state of thedisplacement unit 301. This is e.g. illustrated inFIG. 15 , and allows the proximalexpandable portion 302 to be more securely positioned in relation to theanchor 303 for a more controlled downsizing. - The
distal anchoring portion 303 is expandable to anchor against said CS in the activated state of thedisplacement unit 301. It provides sufficient force against the CS to be fixated relative the proximalexpandable portion 302 when pulling thedistal anchoring portion 303 towards the proximalexpandable portion 302. - The
distal anchoring portion 303 may comprise an expandablecoiled wire 311, seeFIG. 15 . The coiled wire provides for efficient fixation against the CS, since pressure is provided evenly and circumferentially along the length of the coil, while at the same times allows to be easily retracted into thesheath 310 by extending the coil in thelongitudinal direction 304. The coiled wire may be connected to acontrol wire 308,FIG. 15 , which is adapted to stretch the distal anchoring portion to a reduced diameter delivery shape, and reduce tension on the coiled wire in the activated state to expand the distal anchoring portion. Hence, it also allows for easy deployment of the distal anchor in the CS by reducing the tension on the coil so that it can be retracted and expanded in diameter for fixation against the CS. Further, thecoil 311 provides for keeping the body lumen open so that blood flow can be maintained. - The
displacement unit 301 may comprise adelivery wire 309,FIGS. 15 and 18 a-b, adapted to deliver thedistal anchoring portion 303 and to pull thedistal anchoring portion 303 towards the proximalexpandable portion 302 in the activated state, whereby the distance (L) between the two is reduced to the shorter distance (L′), as illustrated inFIGS. 18a-b , to provide the downsizing. Thecontrol wire 308 for the anchoringportion 303 may be pulled simultaneously and with the same displacement so that the anchoring portion maintains its length in thelongitudinal direction 304. - The proximal
expandable portion 303 may be reversibly foldable to an expanded state where the proximalexpandable portion 303 has a diameter substantially larger than the diameter of the CS. This allows for a more stable fixation outside the CS with the advantages mentioned above. - The anchoring portion may comprise a tissue retention portion such as at least one
hook FIGS. 19a-b . Thetissue retention portion portion 303 inside the CS, that allow for efficient downsizing of the valve annulus.FIG. 19b illustrates the case when toretention portions retention portions retention portions - The anchoring
portion 303 may comprise atissue apposition portion 313 having a tissue atraumatic surface, such as an at least partly curved or spherical surface. Thetissue apposition portion 313 provides for exerting a counter force against the wall of the CS, stabilizing the anchoringportion 303, and allowing for theretention portion coil 311 which also keeps the CS vein open. By having a tissue atraumatic surface, thetissue apposition portion 313 enhance the anchoring ability while at the same time reducing the risk of tissue damage to the wall of the CS.FIGS. 19a-b illustrates a spherical surface of the apposition portion, but it may have surface that lies smooth against the CS. - The
tissue retention portion longitudinal direction 304. It may therefore efficiently engage the wall of the CS. For example, theretention portion FIGS. 19a-b , for engaging the tissue. Theretention portion delivery wire 309, such that when the delivery wire is pulled back relative the proximalexpandable portion 302, theretention portion portion 303, and draw the tissue against the proximalexpandable portion 302 to achieve the reduced length (L′) and the downsizing effect. Alternatively, or in addition, theretention portion retention portion delivery wire 309. Thus, theretention portion coil 311, before pushed in thelongitudinal direction 304, where it may assume the heat set radially expanded shape for grasping the tissue as discussed. - The
tissue apposition portion 313 may be controlled and deployed in the same manner as described in the preceding paragraph for theretention portion delivery wire 309 or a separate control wire (not shown), such that the tissue apposition portion can be expandable in a direction substantially perpendicular to thelongitudinal direction 304 for contacting the all of the CS. - The tissue retention portion and said tissue apposition portion may be expandable in substantially opposite directions, as illustrated in
FIGS. 19a-b . This allows thetissue apposition portion 313 to provide a good counter force relative theretention portion retention portion tissue apposition portion 313 is placed against the more sensitive side of the CS. - The displacement unit may comprise, at a radial portion thereof, at least one
radiopaque marker 109 for rotational alignment of the displacement unit in the CS. E.g. thetissue apposition portion 313 may have aradiopaque marker 109 for assisting in orienting away from the myocardial wall. Alternatively, or in addition theretention portion radiopaque marker 109. -
FIG. 20 illustrates amethod 400 for treating a defective mitral valve (V) having an annulus (A) comprising; inserting 401 a flexible and removableelongate displacement unit 301 in a delivery state into a coronary sinus (CS) adjacent the valve, positioning 402 a proximalexpandable portion 302 against atissue wall 305 at the entrance of the CS, positioning 403 adistal anchoring portion 303 inside the CS, activating 404 the displacement unit in an activated state whereby the distal anchoring portion is moved in alongitudinal direction 304 of the displacement unit to reduce the distance between the distal anchoring portion and the proximal expandable portion such that the shape of the annulus is modified to a modified shape (A′), fixating 405 anannuloplasty device 102 at the mitral valve annulus when the modified shape is obtained, whereby the annuloplasty device comprises afixation structure 103 that is adapted to retain the modified shape, removing 406 the elongate displacement unit after temporary activation in the activated state. - The present invention has been described above with reference to specific embodiments. However, other embodiments than the above described are equally possible within the scope of the invention. The different features and steps of the invention may be combined in other combinations than those described. The scope of the invention is only limited by the appended patent claims.
- More generally, those skilled in the art will readily appreciate that all parameters, dimensions, materials, and configurations described herein are meant to be exemplary and that the actual parameters, dimensions, materials, and/or configurations will depend upon the specific application or applications for which the teachings of the present invention is/are used.
Claims (17)
1-20. (canceled)
21. Method for treating a defective mitral valve having an annulus, said method comprising:
inserting a flexible and removable elongate displacement unit in a delivery state into a coronary sinus adjacent said valve,
positioning a distal anchoring portion inside said coronary sinus,
positioning a proximal expandable portion against a tissue wall outside the entrance of said coronary sinus for providing a counter force against said distal anchoring portion,
activating said displacement unit in an activated state whereby said distal anchoring portion is moved in a longitudinal direction of said displacement unit to reduce the distance between said distal anchoring portion and said proximal expandable portion such that the shape of the annulus is modified to a modified shape.
22. Method according to claim 21 , comprising
fixating an annuloplasty device at the mitral valve annulus when said modified shape is obtained, whereby said annuloplasty device comprises a fixation structure that is adapted to retain said modified shape.
23. Method according to claim 21 , comprising
removing said elongate displacement unit after temporary activation in the activated state.
24. Method according to claim 21 , wherein the proximal expandable portion is reversibly foldable to an expanded state from a sheath for positioning against the tissue wall.
25. Method according to claim 24 , comprising
expanding an expandable structure of the proximal expandable portion on either side of the sheath to spread a force symmetrically against a tissue wall outside the entrance of said coronary sinus.
26. Method according to claim 21 , comprising
pivoting the proximal expandable portion towards the longitudinal direction.
27. Method according to claim 24 , comprising
pivoting first and second expandable portions of the proximal expandable portion in opposite directions of the sheath.
28. Method according to claim 27 , comprising
pivoting first and second expandable wires of the proximal expandable portion in opposite directions of the sheath.
29. Method according to claim 21 , comprising
decreasing a radius of curvature of the displacement unit when the displacement unit is transferred from said delivery state to said activated state.
30. Method according to claim 21 , wherein said proximal expandable portion is foldable to an expanded state where said proximal expandable portion has a diameter substantially larger than a diameter of said coronary sinus.
31. Method according to claim 21 , wherein said fixation structure comprises a helix-shaped loop structure, the method comprising
positioning the helix-shaped loop structure on either side of said valve to retain said modified shape of the annulus so that at least a portion of the helix-shaped loop structure conforms to a curvature of said annulus.
32. Method according to claim 31 , comprising
moving at least a portion of the displacement unit an activated shape that at least partly assumes the curvature of said helix-shaped loop structure.
33. Method according to claim 21 , comprising
allowing blood flow through a lumen of the displacement unit, the lumen extending along the longitudinal direction of the displacement unit to improve blood flow through the coronary sinus.
34. Method according to claim 21 , comprising
inflating an inflatable unit of the displacement unit to exert a force on the coronary sinus.
35. Method according to claim 21 , comprising
asymmetrically inflating the inflatable unit of the displacement unit.
36. Method according to claim 34 , comprising
independently inflating a plurality of inflatable units.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/677,553 US20200093600A1 (en) | 2013-05-21 | 2019-11-07 | Medical System For Annuloplasty |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13168600.8 | 2013-05-21 | ||
EP13168600.8A EP2805695A1 (en) | 2013-05-21 | 2013-05-21 | Medical system for annuloplasty |
PCT/EP2014/060434 WO2014187855A1 (en) | 2013-05-21 | 2014-05-21 | Medical system for annuloplasty |
US201514891939A | 2015-11-17 | 2015-11-17 | |
US16/677,553 US20200093600A1 (en) | 2013-05-21 | 2019-11-07 | Medical System For Annuloplasty |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/891,939 Continuation US10517724B2 (en) | 2013-05-21 | 2014-05-21 | Medical system for annuloplasty |
PCT/EP2014/060434 Continuation WO2014187855A1 (en) | 2013-05-21 | 2014-05-21 | Medical system for annuloplasty |
Publications (1)
Publication Number | Publication Date |
---|---|
US20200093600A1 true US20200093600A1 (en) | 2020-03-26 |
Family
ID=48534162
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/891,939 Active US10517724B2 (en) | 2013-05-21 | 2014-05-21 | Medical system for annuloplasty |
US16/677,553 Abandoned US20200093600A1 (en) | 2013-05-21 | 2019-11-07 | Medical System For Annuloplasty |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/891,939 Active US10517724B2 (en) | 2013-05-21 | 2014-05-21 | Medical system for annuloplasty |
Country Status (9)
Country | Link |
---|---|
US (2) | US10517724B2 (en) |
EP (2) | EP2805695A1 (en) |
JP (1) | JP6444384B2 (en) |
CN (2) | CN105208972B (en) |
AU (1) | AU2014270431B2 (en) |
BR (1) | BR112015028653B1 (en) |
CA (1) | CA2909911C (en) |
ES (1) | ES2906552T3 (en) |
WO (1) | WO2014187855A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11234818B2 (en) * | 2018-05-21 | 2022-02-01 | Medtentia International Ltd Oy | Annuloplasty device |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7846123B2 (en) | 2007-04-24 | 2010-12-07 | Emory University | Conduit device and system for implanting a conduit device in a tissue wall |
US8323335B2 (en) | 2008-06-20 | 2012-12-04 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves and methods for using |
CN102869321B (en) | 2010-03-05 | 2015-05-06 | 爱德华兹生命科学公司 | Retaining mechanisms for prosthetic valves |
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
US8657872B2 (en) | 2010-07-19 | 2014-02-25 | Jacques Seguin | Cardiac valve repair system and methods of use |
EP2595569A4 (en) | 2010-07-23 | 2016-02-24 | Edwards Lifesciences Corp | Retaining mechanisms for prosthetic valves |
EP2667792B1 (en) | 2011-01-28 | 2020-05-06 | Apica Cardiovascular Limited | Systems for sealing a tissue wall puncture |
US9320875B2 (en) | 2011-02-01 | 2016-04-26 | Emory University | Systems for implanting and using a conduit within a tissue wall |
US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
US10500038B1 (en) | 2011-05-20 | 2019-12-10 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Prosthetic mitral valve, and methods and devices for deploying the prosthetic mitral valve |
US9078747B2 (en) | 2011-12-21 | 2015-07-14 | Edwards Lifesciences Corporation | Anchoring device for replacing or repairing a heart valve |
EP3705091B1 (en) | 2012-01-31 | 2024-07-03 | Mitral Valve Technologies Sàrl | Mitral valve docking devices and systems |
EP2852354B1 (en) | 2012-05-20 | 2020-05-13 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Prosthetic mitral valve |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
WO2014117087A1 (en) | 2013-01-25 | 2014-07-31 | Apica Cardiovascular Limited | Systems and methods for percutaneous access, stabilization and closure of organs |
EP2968717A4 (en) | 2013-03-15 | 2017-02-22 | Apk Advanced Medical Technologies, Inc. | Devices, systems, and methods for implanting and using a connnector in a tissue wall |
US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
SG10202103500PA (en) | 2013-08-12 | 2021-05-28 | Mitral Valve Tech Sarl | Apparatus and methods for implanting a replacement heart valve |
CA3194922A1 (en) | 2013-08-14 | 2015-02-19 | Mitral Valve Technologies Sarl | Replacement heart valve apparatus and methods |
US10195028B2 (en) | 2013-09-10 | 2019-02-05 | Edwards Lifesciences Corporation | Magnetic retaining mechanisms for prosthetic valves |
US9622863B2 (en) | 2013-11-22 | 2017-04-18 | Edwards Lifesciences Corporation | Aortic insufficiency repair device and method |
WO2015127264A1 (en) | 2014-02-20 | 2015-08-27 | Mitral Valve Technologies Sarl | Coiled anchor for supporting prosthetic heart valve, prosthetic heart valve, and deployment device |
CA3189691A1 (en) | 2014-02-21 | 2015-08-27 | Mitral Valve Technologies Sarl | Devices, systems and methods for delivering a prosthetic mitral valve and anchoring device |
US10016272B2 (en) | 2014-09-12 | 2018-07-10 | Mitral Valve Technologies Sarl | Mitral repair and replacement devices and methods |
US10485909B2 (en) * | 2014-10-31 | 2019-11-26 | Thoratec Corporation | Apical connectors and instruments for use in a heart wall |
US10231834B2 (en) | 2015-02-09 | 2019-03-19 | Edwards Lifesciences Corporation | Low profile transseptal catheter and implant system for minimally invasive valve procedure |
US10039637B2 (en) | 2015-02-11 | 2018-08-07 | Edwards Lifesciences Corporation | Heart valve docking devices and implanting methods |
US11833034B2 (en) | 2016-01-13 | 2023-12-05 | Shifamed Holdings, Llc | Prosthetic cardiac valve devices, systems, and methods |
EP3407835A4 (en) | 2016-01-29 | 2019-06-26 | Neovasc Tiara Inc. | Prosthetic valve for avoiding obstruction of outflow |
US10363130B2 (en) | 2016-02-05 | 2019-07-30 | Edwards Lifesciences Corporation | Devices and systems for docking a heart valve |
US10828150B2 (en) | 2016-07-08 | 2020-11-10 | Edwards Lifesciences Corporation | Docking station for heart valve prosthesis |
CR20190069A (en) | 2016-08-26 | 2019-05-14 | Edwards Lifesciences Corp | Heart valve docking coils and systems |
US10722359B2 (en) | 2016-08-26 | 2020-07-28 | Edwards Lifesciences Corporation | Heart valve docking devices and systems |
US10357361B2 (en) | 2016-09-15 | 2019-07-23 | Edwards Lifesciences Corporation | Heart valve pinch devices and delivery systems |
CA3042588A1 (en) | 2016-11-21 | 2018-05-24 | Neovasc Tiara Inc. | Methods and systems for rapid retraction of a transcatheter heart valve delivery system |
HUE061376T2 (en) | 2016-12-16 | 2023-06-28 | Edwards Lifesciences Corp | Deployment systems and tools for delivering an anchoring device for a prosthetic valve |
US10813749B2 (en) | 2016-12-20 | 2020-10-27 | Edwards Lifesciences Corporation | Docking device made with 3D woven fabric |
WO2018118717A1 (en) | 2016-12-20 | 2018-06-28 | Edwards Lifesciences Corporation | Systems and mechanisms for deploying a docking device for a replacement heart valve |
US11654023B2 (en) | 2017-01-23 | 2023-05-23 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
US11185406B2 (en) | 2017-01-23 | 2021-11-30 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
US11013600B2 (en) | 2017-01-23 | 2021-05-25 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
USD867595S1 (en) | 2017-02-01 | 2019-11-19 | Edwards Lifesciences Corporation | Stent |
US10842619B2 (en) | 2017-05-12 | 2020-11-24 | Edwards Lifesciences Corporation | Prosthetic heart valve docking assembly |
EP3630008B1 (en) * | 2017-05-30 | 2024-03-27 | University of Massachusetts | System for treating neurovascular compression |
CN110891526A (en) | 2017-06-30 | 2020-03-17 | 爱德华兹生命科学公司 | Locking and releasing mechanism for transcatheter implantable devices |
JP7277389B2 (en) | 2017-06-30 | 2023-05-18 | エドワーズ ライフサイエンシーズ コーポレイション | Docking station for transcatheter valves |
USD890333S1 (en) | 2017-08-21 | 2020-07-14 | Edwards Lifesciences Corporation | Heart valve docking coil |
CA3073834A1 (en) | 2017-08-25 | 2019-02-28 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
AU2018337712B2 (en) * | 2017-09-22 | 2024-06-27 | Medtentia International Ltd Oy | Medical system for annuloplasty |
CN110192901A (en) | 2018-02-27 | 2019-09-03 | 上海科赐医疗技术有限公司 | Sacculus pulling device and its manufacturing method |
EP3860519A4 (en) | 2018-10-05 | 2022-07-06 | Shifamed Holdings, LLC | Prosthetic cardiac valve devices, systems, and methods |
CN113271890A (en) | 2018-11-08 | 2021-08-17 | 内奥瓦斯克迪亚拉公司 | Ventricular deployment of transcatheter mitral valve prosthesis |
WO2020185597A1 (en) | 2019-03-08 | 2020-09-17 | Neovasc Tiara Inc. | Retrievable prosthesis delivery system |
US11471282B2 (en) | 2019-03-19 | 2022-10-18 | Shifamed Holdings, Llc | Prosthetic cardiac valve devices, systems, and methods |
US11793641B2 (en) * | 2019-03-28 | 2023-10-24 | Hvr Cardio Oy | Medical system for annuloplasty |
AU2020256195B2 (en) | 2019-04-01 | 2022-10-13 | Neovasc Tiara Inc. | Controllably deployable prosthetic valve |
AU2020271896B2 (en) | 2019-04-10 | 2022-10-13 | Neovasc Tiara Inc. | Prosthetic valve with natural blood flow |
EP3972673A4 (en) | 2019-05-20 | 2023-06-07 | Neovasc Tiara Inc. | Introducer with hemostasis mechanism |
CN114144144A (en) | 2019-06-20 | 2022-03-04 | 内奥瓦斯克迪亚拉公司 | Low-profile prosthetic mitral valve |
WO2021028867A1 (en) | 2019-08-14 | 2021-02-18 | Innovalve Bio Medical Ltd. | Atrioventricular valve replacement |
EP4061467A4 (en) | 2019-11-18 | 2023-11-15 | HVR Cardio Oy | Catheter for manipulating anatomical structure and relative position of the catheter and the anatomical structure |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0306010A3 (en) * | 1987-08-31 | 1990-01-24 | John W. Danforth | Controllable flexibility catheter with eccentric stiffener |
SE514718C2 (en) | 1999-06-29 | 2001-04-09 | Jan Otto Solem | Apparatus for treating defective closure of the mitral valve apparatus |
US7192442B2 (en) * | 1999-06-30 | 2007-03-20 | Edwards Lifesciences Ag | Method and device for treatment of mitral insufficiency |
US6676698B2 (en) * | 2000-06-26 | 2004-01-13 | Rex Medicol, L.P. | Vascular device with valve for approximating vessel wall |
US7144363B2 (en) | 2001-10-16 | 2006-12-05 | Extensia Medical, Inc. | Systems for heart treatment |
US7052487B2 (en) * | 2001-10-26 | 2006-05-30 | Cohn William E | Method and apparatus for reducing mitral regurgitation |
US7857846B2 (en) * | 2001-12-05 | 2010-12-28 | Cardiac Dimensions, Inc. | Device and method for modifying the shape of a body organ |
US6764510B2 (en) * | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
US7314485B2 (en) * | 2003-02-03 | 2008-01-01 | Cardiac Dimensions, Inc. | Mitral valve device using conditioned shape memory alloy |
US20040254600A1 (en) * | 2003-02-26 | 2004-12-16 | David Zarbatany | Methods and devices for endovascular mitral valve correction from the left coronary sinus |
SE0300854D0 (en) | 2003-03-26 | 2003-03-26 | Oeyvind Reitan | Device for the treatment of a heart valve insufficiency |
JP4456605B2 (en) * | 2003-05-27 | 2010-04-28 | ビアカー・インコーポレーテッド | Method and apparatus for improving mitral valve function |
JP4794460B2 (en) * | 2003-12-19 | 2011-10-19 | カーディアック ディメンションズ インコーポレイテッド | Device for changing the shape of a body organ |
JP2007052398A (en) * | 2005-07-22 | 2007-03-01 | Sony Corp | Light source apparatus and liquid crystal display device |
JP4958907B2 (en) * | 2005-09-07 | 2012-06-20 | メドテンチア インターナショナル エルティーディ オーワイ | Apparatus and method for improving heart valve function |
CA2636286C (en) * | 2006-01-06 | 2014-10-21 | Cordis Corporation | A medical delivery system and method for delivery of a medically useful payload |
US7637946B2 (en) * | 2006-02-09 | 2009-12-29 | Edwards Lifesciences Corporation | Coiled implant for mitral valve repair |
US7503932B2 (en) * | 2006-04-11 | 2009-03-17 | Cardiac Dimensions, Inc. | Mitral valve annuloplasty device with vena cava anchor |
EP2072027B1 (en) * | 2007-12-21 | 2020-06-17 | Medtentia International Ltd Oy | pre-annuloplasty device and method |
US20100168665A1 (en) * | 2008-12-30 | 2010-07-01 | Wilson-Cook Medical Inc. | Segmented balloon for catheter tip deflection |
JP5774594B2 (en) * | 2009-10-14 | 2015-09-09 | ハート・リペアー・テクノロジーズ・インコーポレーテッド | Percutaneous intraoral band for mitral valve repair |
EP2907479A1 (en) * | 2014-02-18 | 2015-08-19 | Medtentia International Ltd Oy | A system and a method for delivery of an annuloplasty implant |
-
2013
- 2013-05-21 EP EP13168600.8A patent/EP2805695A1/en not_active Withdrawn
-
2014
- 2014-05-21 CN CN201480028188.9A patent/CN105208972B/en active Active
- 2014-05-21 WO PCT/EP2014/060434 patent/WO2014187855A1/en active Application Filing
- 2014-05-21 EP EP14725456.9A patent/EP2999434B1/en active Active
- 2014-05-21 ES ES14725456T patent/ES2906552T3/en active Active
- 2014-05-21 CN CN201710997889.9A patent/CN107736953B/en active Active
- 2014-05-21 JP JP2016514391A patent/JP6444384B2/en active Active
- 2014-05-21 AU AU2014270431A patent/AU2014270431B2/en active Active
- 2014-05-21 CA CA2909911A patent/CA2909911C/en active Active
- 2014-05-21 US US14/891,939 patent/US10517724B2/en active Active
- 2014-05-21 BR BR112015028653-4A patent/BR112015028653B1/en not_active IP Right Cessation
-
2019
- 2019-11-07 US US16/677,553 patent/US20200093600A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11234818B2 (en) * | 2018-05-21 | 2022-02-01 | Medtentia International Ltd Oy | Annuloplasty device |
Also Published As
Publication number | Publication date |
---|---|
ES2906552T3 (en) | 2022-04-19 |
CA2909911C (en) | 2022-05-24 |
CN105208972B (en) | 2017-11-24 |
BR112015028653B1 (en) | 2022-11-08 |
JP2016518947A (en) | 2016-06-30 |
US10517724B2 (en) | 2019-12-31 |
BR112015028653A8 (en) | 2019-12-31 |
AU2014270431A1 (en) | 2015-11-12 |
CN107736953A (en) | 2018-02-27 |
EP2999434B1 (en) | 2021-11-24 |
CA2909911A1 (en) | 2014-11-27 |
WO2014187855A1 (en) | 2014-11-27 |
EP2805695A1 (en) | 2014-11-26 |
CN107736953B (en) | 2020-01-03 |
JP6444384B2 (en) | 2018-12-26 |
BR112015028653A2 (en) | 2017-07-25 |
EP2999434A1 (en) | 2016-03-30 |
US20160095705A1 (en) | 2016-04-07 |
CN105208972A (en) | 2015-12-30 |
AU2014270431B2 (en) | 2019-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200093600A1 (en) | Medical System For Annuloplasty | |
US20240041604A1 (en) | Medical System for Annuloplasty | |
US11234818B2 (en) | Annuloplasty device | |
US20230255771A1 (en) | Annuloplasty device | |
US20220257378A1 (en) | Annuloplasty Device | |
US11491008B2 (en) | Annuloplasty device | |
US11793641B2 (en) | Medical system for annuloplasty | |
EP4400077A1 (en) | Annuloplasty device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |